Ischemic White Matter Damage

Myelin Biology and Disorders

Volumn 2, Issue , 2004, Pages 985-1007

  Stys, Peter K ^a   Waxman, Stephen G ^b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903098567     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012439510-7/50094-2     Document Type: Chapter

References (177)

1. Agrawal S.K., Fehlings M.G. Mechanisms of secondary injury to spinal cord axons in vitro-role of Na+, Na+-K+-ATPase, the Na+-H+ exchanger, and the Na+-Ca2+ exchanger. J. Neurosci. 1996, 16:545-552.
2. Agrawal S.K., Fehlings M.G. The effect of the sodium channel blocker QX-314 on recovery after acute spinal cord injury. J Neurotrauma 1997, 14:81-88.
3. Agrawal S.K., Fehlings M.G. Role of NMDA and non-NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J. Neurosci. 1997, 17:1055-1063.
4. Agrawal S.K., Theriault E., Fehlings M.G. Role of group I metabotropic glutamate receptors in traumatic spinal cord white matter injury. J Neurotrauma 1998, 15:929-941.
5. Agrawal S.K., Nashmi R., Fehlings M.G. Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury. Neuroscience 2000, 99:179-188.
6. Akins P.T., Atkinson R.P. Glutamate AMPA receptor antagonist treatment for ischaemic stroke. Curr Med Res Opin 2002, 18(Suppl 2):s9-s93.
7. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 1994, 14:5559-5569.
8. Attwell D., Barbour B., Szatkowski M. Nonvesicular release of neurotransmitter. Neuron 1993, 11:401-407.
9. Bechtold D.A., Kapoor R., Smith K.J. Axonal protection in experimental inflammatory demyelinating disease achieved by flecainide therapy. Soc. Neurosci. Abstr.: 93.7 2002.
10. Bi R., Bi X., Baudry M. Phosphorylation regulates calpain-mediated truncation of glutamate ionotropic receptors. Brain Res 1998, 797:154-158.
11. Bi X., Chen J., Baudry M. Calpain-mediated proteolysis of GluR1 subunits in organotypic hippocampal cultures following kainic acid treatment. Brain Res 1998, 781:355-357.
12. Bi X., Rong Y., Chen J., Dang S., Wang Z., Baudry M. Calpain-mediated regulation of NMDA receptor structure and function. Brain Res 1998, 790:245-253.
13. Bjartmar C., Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences. Curr. Opin. Neurol. 2001, 14:271-278.
14. Black J.A., Dib-Hajj S., Baker D., Newcombe J., Cuzner M.L., Waxman S.G. Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11598-11602.
15. Blaustein M.P., Lederer W.J. Sodium/calcium exchange: Its physiological implications. Physiol. Rev. 1999, 79:763-854.
16. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994, 36:778-786.
17. Bolanos J.P., Almeida A., Stewart V., Peuchen S., Land J.M., Clark J.B., Heales S.J. Nitric oxide - mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases. J Neurochem 1997, 68:2227-2240.
18. o during anoxia in CNS white matter. Neuroreport 1998, 9:1997-2000.
19. Brown A.M., Wender R., Ransom B.R. Ionic mechanisms of aglycemic axon injury in mammalian central white matter. J. Cereb. Blood Flow Metab. 2001, 21:385-395.
20. Brown A.M., Westenbroek R.E., Catterall W.A., Ransom B.R. Axonal L-type Ca(2+) channels and anoxic injury in rat CNS white matter. J. Neurophysiol. 2001, 85:900-911.
21. Buki A., Povlishock J.T., Siman R., Christman C.W. the role of calpain-mediated spectrin proteolysis (CMSP) in traumatically induced axonal injury (AI). Soc. Neurosci. Abstr. 1998, 24:252.
22. Buki A., Siman R., Trojanowski J.Q., Povlishock J.T. The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J. Neuropathol. Exp. Neurol. 1999, 58:365-375.
23. Caldwell J.H., Schaller K.L., Lasher R.S., Peles E., Levinson S.R. Sodium channel Nav 1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc. Natl. Acad. Sci. U.S.A. 2000.
24. Callahan D.J., Engle M.J., Volpe J.J. Hypoxic injury to developing glial cells: Protective effect of high glucose. Pediatr Res 1990, 27:186-190.
25. Casha S., Yu W.R., Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001, 103:203-218.
26. Catterall W.A. Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu. Rev. Pharmacol. Toxicol. 1980, 20:15-43.
27. Chen C.J., Liao S.L., Kuo J.S. Gliotoxic action of glutamate on cultured astrocytes. J Neurochem 2000, 75:1557-1565.
28. Chih C.P., Lipton P., Roberts E.L. Do active cerebral neurons really use lactate rather than glucose?. Trends Neurosci. 2001, 24:573-578.
29. Clarke D.D., Sokoloff L. Circulation and energy metabolism of the brain. Basic Neurochemistry 1994, 645-680. Raven Press, Philadelphia. 5th ed. G.J. Siegel, B.W. Agranoff, R.W. Albers, P.B. Molinoff (Eds.).
30. Collins J.G. Types of injuries by selected characteristics. Vital Health Stat. 1990, 1-68.
31. Cooper C.E. Nitric oxide and cytochrome oxidase: Substrate, inhibitor or effector?. Trends Biochem. Sci. 2002, 27:33-39.
32. Covault J., Liu Q.Y., el-Deeb S. Calcium-activated proteolysis of intracellular domains in the cell adhesion molecules NCAM and N-cadherin. Brain Res Mol Brain Res 1991, 11:11-16.
33. Cross A.H., Manning P.T., Keeling R.M., Schmidt R.E., Misko T.P. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 1998, 88:45-56.
34. Darley U.V., Stone D., Smith D., Martin J.F. Mitochondria, oxygen and reperfusion damage. Ann. Med. 1991, 23:583-588.
35. David J.C., Yamada K.A., Bagwe M.R., Goldberg M.P. AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked. J. Neurosci. 1996, 16:200-209.
36. DeGraba T.J., Pettigrew L.C. Why do neuroprotective drugs work in animals but not humans?. Neurol Clin 2000, 18:475-493.
37. Deshpande R.V., Goust J.M., Hogan E.L., Banik N.L. Calpain secreted by activated huma lymphoid cells degrades myelin. J. Neurosci. Res. 1995, 42:259-265.
38. Textbook of Biochemistry 1992, Wiley-Liss, New York. 3rd ed. T.M. Devlin (Ed.).
39. Dohmen C., Kumura E., Rosner G., Heiss W.D., Graf R. Adenosine in relation to calcium homeostasis: Comparison between gray and white matter ischemia. J Cereb Blood Flow Metab 2001, 21:503-510.
40. Dong H., Dunn J., Lytton J. Stoichiometry of the Cardiac Na+/Ca2+ exchanger NCX1.1 measured in transfected HEK cells. Biophys J 2002, 82:1943-1952.
41. Dong H., Light P.E., French R.J., Lytton J. Electrophysiological characterization and ionic stoichiometry of the rat brain K(+)-dependent NA(+)/CA(2+) exchanger, NCKX2. J Biol Chem 2001, 276:25919-25928.
42. Eng D.L., Gordon T.R., Kocsis J.D., Waxman S.G. Current-clamp analysis of a time-dependent rectification in rat optic nerve. J. Physiol. (Lond.) 1990, 421:185-202.
43. Erecinska M., Dagani F. Relationships between the neuronal sodium/potassium pump and energy metabolism. Effects of K+, Na+, and adenosine triphosphate in isolated brain synaptosomes. J. Gen. Physiol. 1990, 95:591-616.
44. Erecinska M., Silver I.A. ATP and brain function. J. Cereb. Blood Flow Metab. 1989, 9:2-19.
45. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120:393-399.
46. Fern R., Davis P., Waxman S.G., Ransom B.R. Axon conduction and survival in CNS white matter during energy deprivation: A developmental study. J. Neurophysiol. 1998, 79:95-105.
47. Fern R., Moller T. Rapid ischemic cell death in immature oligodendrocytes: A fatal glutamate release feedback loop. J Neurosci 2000, 20:34-42.
48. Fern R., Ransom B.R., Waxman S.G. Voltage-gated calcium channels in CNS white matter: Role in anoxic injury. J. Neurophysiol. 1995, 74:369-377.
49. Fern R., Ransom B.R., Waxman S.G. Autoprotective mechanisms in the CNS: Some new lessons from white matter. Mol. Chem. Neuropathol. 1996, 27:107-129.
50. Fern R., Ransom B.R., Waxman S.G. White matter stroke: Autoprotective mechanisms with therapeutic implications. Cerebrovasc. Dis. 1996, 6:59-65.
51. Fern R., Ransom B., Stys P.K., Waxman S.G. Pharmacological protection of CNS white matter during anoxia: Actions of phenytoin, carbamazepine and diazepam. J. Pharmacol. Exp. Ther. 1993, 266:1549-1555.
52. Fern R., Waxman S.G., Ransom B.R. Modulation of anoxic injury in CNS white matter by adenosine and interaction between adenosine and GABA. J. Neurophysiol. 1994, 72:2609-2616.
53. Fern R., Waxman S.G., Ransom B.R. Endogenous GABA attenuates CNS white matter dysfunction following anoxia. J. Neurosci. 1995, 15:699-708.
54. Fisher C.M. Lacunar strokes and infarcts: A review. Neurology 1982, 32:871-876.
55. Follett P.L., Rosenberg P.A., Volpe J.J., Jensen F.E. NBQX attenuates excitotoxic injury in developing white matter. J. Neurosci. 2000, 20:9235-9241.
56. Fonnum F. Glutamate: A neurotransmitter in mammalian brain. J. Neurochem. 1984, 42:1-11.
57. Garcia-Barcina J.M., Matute C. Expression of kainate-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Eur. J. Neurosci. 1996, 8:2379-2387.
58. Garcia-Barcina J.M., Matute C. AMPA-selective glutamate receptor subunits in glial cells of the adult bovine white matter. Brain Res. Mol. Brain Res. 1998, 53:270-276.
59. Garthwaite G., Goodwin D.A., Batchelor A.M., Leeming K., Garthwaite J. Nitric oxide toxicity in CNS white matter: An in vitro study using rat optic nerve. Neuroscience 2002, 109:145-155.
60. Gellerman D.M., Bi X., Baudry M. NMDA receptor-mediated regulation of AMPA receptor properties in organotypic hippocampal slice cultures. J Neurochem 1997, 69:131-136.
61. Gibson C.J. Overview of spinal cord injury. Phys. Med. Rehab. Clin. North Am. 1992, 3:699-709.
62. Graf R., Dohmen C., Kumura E., Rosner G., Heiss W.-D. Extracellular shifts of GABA, adenosine and ion activities in cortical gray and subcortical white matter during global ischemia in cats. Soc. Neurosci. Abstr. 1998, 24:983.
63. Griffiths R., Dunlop J., Gorman A., Senior J., Grieve A. L-trans-pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters. Biochem. Pharmacol. 1994, 47:267-274.
64. Hell J.W., Westenbroek R.E., Breeze L.J., Wang K.K., Chavkin C., Catterall W.A. N-methyl-D-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons. Proc Natl Acad Sci U S A 1996, 93:3362-3367.
65. Hewitt K.E., Stys P.K., Lesiuk H.J. The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury. Brain Res. 2001, 898:281-287.
66. Imaizumi T., Kocsis J.D., Waxman S.G. Anoxic injury in the rat spinal cord-pharmacological evidence for multiple steps in Ca2+-dependent injury of the dorsal columns. J. Neurotrauma 1997, 14:299-311.
67. Imaizumi T., Kocsis J.D., Waxman S.G. The role of voltage-gated Ca2+ channels in anoxic injury of spinal cord white matter. Brain Res. 1999, 817:84-92.
68. Jalc P., Marsala J., Jalcova H. Postischemic reperfusion causes a massive calcium overload in the myelinated spinal cord fibers. Mol. Chem. Neuropathol. 1995, 25:143-153.
69. Jensen A.M., Chiu S.Y. Expression of glutamate receptor genes in white matter: Developing and adult rat optic nerve. J. Neurosci. 1993, 13:1664-1675.
70. Jiang Q., Stys P.K. Calpain inhibitors confer biochemical, but not electrophysiological, protection against anoxia in rat optic nerves. J. Neurochem. 2000, 74:2101-2107.
71. Kampfl A., Posmantur R.M., Zhao X., Schmutzhard E., Clifton G.L., Hayes R.L. Mechanisms of calpain proteolysis following traumatic brain injury: Implications for pathology and therapy. A review and update. J. Neurotrauma 1997, 14:121-134.
72. Kanellopoulos G.K., Xu X.M., Hsu C.Y., Lu X., Sundt T.M., Kouchoukos N.T. White matter injury in spinal cord ischemia: Protection by AMPA/kainate glutamate receptor antagonism. Stroke 2000, 31:1945-1952.
73. Kapoor R., Davies M., Blaker P.A., et al. Protection of axons from degeneration caused by nitric oxide can be achieved using blockers of the sodium channel and sodium-calcium exchanger. Ann. Neurol. 2003, in press.
74. Khodorov B.I. Role of inactivation in local anesthetic action. Ann. N. Y. Acad. Sci. 1991, 625:224-248.
75. Kiedrowski L., Czyz A., Li X.F., Lytton J. Preferential expression of plasmalemmal K-dependent Na+/Ca2+ exchangers in neurons versus astrocytes. Neuroreport 2002, 13:1529-1532.
76. Koizumi J. Glycogen in the central nervous system. Prog. Histochem. Cytochem. 1974, 6:1-37.
77. Kornek B., Lassmann H. Axonal pathology in multiple sclerosis. A historical note. Brain Pathol. 1999, 9:651-656.
78. Kornek B., Storch M.K., Bauer J., Djamshidian A., Weissert R., Wallstroem E., Stefferl A., Zimprich F., Olsson T., Linington C., Schmidbauer M., Lassmann H. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001, 124:1114-1124.
79. Kriegler S., Chiu S.Y. Calcium signaling of glial cells along mammalian axons. J. Neurosci. 1993, 13:4229-4245.
80. Lees K.R. Neuroprotection. Br Med Bull 2000, 56:401-412.
81. Leppanen L.L., Stys P.K. Ion transport and membrane potential in CNS myelinated axons. II: Effects of metabolic inhibition. J. Neurophysiol. 1997, 78:2095-2107.
82. Levy L.M., Warr O., Attwell D. Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake. J. Neurosci. 1998, 18:9620-9628.
83. Li S., Jiang Q., Stys P.K. Important role of reverse Na(+)-Ca(2+) exchange in spinal cord white matter injury at physiological temperature. J. Neurophysiol. 2000, 84:1116-1119.
84. Li S., Mealing G.A., Morley P., Stys P.K. Novel injury mechanism in anoxia and trauma of spinal cord white matter: Glutamate release via reverse Na+-dependent glutamate transport. J. Neurosci. 1999, 19:RC16.
85. Li S., Stys P.K. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J. Neurosci. 2000, 20:1190-1198.
86. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79:1431-1568.
87. Lo A.C., Black J.A., Waxman S.G. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport 2002, 13:1909-1912.
88. LoPachin R.M., Gaughan C.L., Lehning E.J., Kaneko Y., Kelly T.M., Blight A. Experimental spinal cord injury: Spatiotemporal characterization of elemental concentrations and water contents in axons and neuroglia. J. Neurophysiol. 1999, 82:2143-2153.
89. LoPachin R.M., Stys P.K. Elemental composition and water content of rat optic nerve myelinated axons and glial cells: Effects of in vitro anoxia and reoxygenation. J. Neurosci. 1995, 15:6735-6746.
90. Maas A.I. Neuroprotective agents in traumatic brain injury. Expert Opin Investig Drugs 2001, 10:753-767.
91. MacManus J.P., Buchan A.M. Apoptosis after experimental stroke: Fact or fashion?. J Neurotrauma 2000, 17:899-914.
92. Malek S., Coderre E., Stys P.K. K-Cl cotransporter mediates injurious Cl flux in anoxic/ischemic CNS white matter. J. Neurosci. 2002, in prep.
93. Malek S., Stys P.K. Effects of Na and Cl fluxes during anoxia on the compound action potential of rat optic nerve. Soc. Neurosci. Abstr. 95.9 2002.
94. Matsuo A., Akiguchi I., Lee G.C., McGeer E.G., McGeer P.L., Kimura J. Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol 1998, 153:735-744.
95. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10229-10234.
96. Matute C., Alberdi E., Ibarretxe G., Sanchez-Gomez M.V. Excitotoxicity in glial cells. Eur J Pharmacol 2002, 447:239-246.
97. Matute C., Sanchez-Gomez M.V., Martinez-Millan L., Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8830-8835.
98. Maxwell W.L., Povlishock J.T., Graham D.L. A mechanistic analysis of nondisruptive axonal injury: A review. J. Neurotrauma 1997, 14:419-440.
99. McCracken E., Dewar D., Hunter A.J. White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat. Brain Res 2001, 892:329-335.
100. McCracken E., Fowler J.H., Dewar D., Morrison S., McCulloch J. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J Cereb Blood Flow Metab 2002, 22:1090-1097.
101. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 1998, 4:291-297.
102. Meschia J.F., Miller D.A., Brott T.G. Thrombolytic treatment of acute ischemic stroke. Mayo Clin Proc 2002, 77:542-551.
103. Nicholls D.G., Budd S.L. Mitochondria and neuronal survival. Physiol. Rev. 2000, 80:315-360.
104. Nikolaeva M.A., Stys P.K. Calcium changes in ischemic rat optic nerve axons studied by confocal microscopy. Soc. Neurosci. Abstr. 299.6 2002.
105. Oka A., Belliveau M.J., Rosenberg P.A., Volpe J.J. Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J. Neurosci. 1993, 13:1441-1453.
106. Orrenius S., Nicotera P. Mechanisms of calcium-related cell death. Cellular and Molecular Mechanisms of Ischemic Brain Damage 1996, 137-152. Raven Press, New York. B.K. Siesjo, T. Wieloch (Eds.).
107. 2+ channel activation of ryanodine receptors. Neuron 2003, 40:53-63.
108. Pasti L., Zonta M., Pozzan T., Vicini S., Carmignoto G. Cytosolic calcium oscillations in astrocytes may regulate exocytotic release of glutamate. J. Neurosci. 2001, 21:477-484.
109. Pitt D., Werner P., Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 2000, 6:67-70.
110. Povlishock J.T., Christman C.W. Diffuse axonal injury. The Axon: Structure, Function and Pathophysiology 1995, 504-529. Oxford University Press, New York. S.G. Waxman, J.D. Kocsis, P.K. Stys (Eds.).
111. Ragsdale D.S., McPhee J.C., Scheuer T., Catterall W.A. Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc Natl Acad Sci U S A 1996, 93:9270-9275.
112. Rami A., Ferger D., Krieglstein J. Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci. Res. 1997, 27:93-97.
113. + and pH in mammalian central white matter. J. Cereb. Blood Flow Metab. 1992, 12:593-602.
114. Ren Y., Ridsdale A., Coderre E., Stys P.K. Calcium imaging in live rat optic nerve myelinated axons in vitro using confocal laser microscopy. J. Neurosci. Meth. 2000, 102:165-176.
115. Rieckmann P., Maurer M. Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis. Curr Opin Neurol 2002, 15:361-370.
116. Rieckmann P., Smith K.J. Multiple sclerosis: More than inflammation and demyelination. Trends Neurosci 2001, 24:435-437.
117. Rios E., Brum G. Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle. Nature 1987, 325:717-720.
118. + homeostasis in rat spinal cord astrocytes. J. Neurosci. 1998, 18:3554-3562.
119. Rosenberg L.J., Teng Y.D., Wrathall J.R. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J. Neurosci. 1999, 19:464-475.
120. Rosenberg L.J., Teng Y.D., Wrathall J.R. Effects of the sodium channel blocker tetrodotoxin on acute white matter pathology after experimental contusive spinal cord injury. J. Neurosci. 1999, 19:6122-6133.
121. Rutledge E.M., Aschner M., Kimelberg H.K. Pharmacological characterization of swelling-induced D-[3H]aspartate release from primary astrocyte cultures. Am. J. Physiol. 1998, 274:C1511-C1520.
122. Salamino F., Sparatore B., Melloni E., Michetti M., Viotti P.L., Pontremoli S., Carafoli E. The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte. Cell Calcium 1994, 15:28-35.
123. Schaecher K.E., Shields D.C., Banik N.L. Mechanism of myelin breakdown in experimental demyelination: A putative role for calpain. Neurochem Res 2001, 26:731-737.
124. Schanne F.A., Kane A.B., Young E.E., Farber J.L. Calcium-dependence of toxic cell death: A final common pathway. Science 1979, 206:700-702.
125. Schumacher P.A., Siman R.G., Fehlings M.G. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J. Neurochem. 2000, 74:1646-1655.
126. Shields D.C., Schaecher K.E., Saido T.C., Banik N.L. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:11486-11491.
127. Silver I.A., Deas J., Erecinska M. Ion homeostasis in brain cells: Differences in intracellular ion responses to energy limitation between cultured neurons and glial cells. Neuroscience 1997, 78:589-601.
128. Smith K.J., Kapoor R., Hall S.M., Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 2001, 49:470-476.
129. Smith M.R., Smith R.D., Plummer N.W., Meisler M.H., Goldin A.L. Functional analysis of the mouse Scn8a sodium channel. J. Neurosci. 1998, 18:6093-6102.
130. Smith T., Groom A., Zhu B., Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000, 6:62-66.
131. Sorg O., Magistretti P.J. Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Res 1991, 563:227-233.
132. Sosin D.M., Sniezek J.E., Thurman D.J. Incidence of mild and moderate brain injury in the United States, 1991. Brain Inj. 1996, 10:47-54.
133. Steinhauser C., Gallo V. News on glutamate receptors in glial cells. Trends Neurosci 1996, 19:339-345.
134. Stryer L. Biochemistry 1988, W. H. Freeman, New York.
135. Stys P.K. Protective effects of antiarrhythmic agents against anoxic injury in CNS white matter. J. Cereb. Blood Flow Metab. 1995, 15:425-432.
136. Stys P.K. Anoxic and ischemic injury of myelinated axons in CNS white matter: From mechanistic concepts to therapeutics. J. Cereb. Blood Flow Metab. 1998, 18:2-25.
137. Stys P.K., Hubatsch D.A., Leppanen L.L. Effects of K+ channel blockers on the anoxic response of central myelinated axons. NeuroReport 1998, 9:447-453.
138. Stys P.K., Jiang Q. Ca2+-mediated calpain-dependent neurofilament breakdown in anoxic and ischemic central white matter axons. Neurosci. Lett. 2002, 328:150-154.
139. Stys P.K., Lehning E.J., Sauberman A.J., LoPachin R.M. Intracellular concentrations of major ions in rat myelinated axons and glia: Calculations based on electron probe X-ray microanalyses. J. Neurochem. 1997, 68:1920-1928.
140. Stys P.K., Lesiuk H. Correlation between electrophysiological effects of mexiletine and ischemic 1996.
141. Stys P.K., Li S. Glutamate-induced white matter injury: Excitotoxicity without synapses. The Neuroscientist 2000, 6:230-233.
142. Stys P.K., LoPachin R.M. Elemental composition and water content of rat optic nerve myelinated axons during in vitro post-anoxia reoxygenation. Neuroscience 1996, 73:1081-1090.
143. protection of CNS white matter. Neuroscience 71:27-36.
144. Stys P.K., LoPachin R.M. Mechanisms of ion flux in anoxic myelinated CNS axons. Neuroscience 1998, 82:21-32.
145. Stys P.K., Ouardouz M. Role of glutamate receptors in spinal cord dorsal column ischemia. Soc. Neurosci. Abstr.: 298.298 2002.
146. Stys P.K., Ransom B.R., Waxman S.G. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J. Neurophysiol. 1992, 67:236-240.
147. Stys P.K., Ransom B.R., Waxman S.G., Davis P.K. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc. Natl. Acad. Sci. USA 1990, 87:4212-4216.
148. + conductance in rat optic nerve axons. Proc. Natl. Acad. Sci. USA. 1993, 90:6976-6980.
149. 2+ exchanger. J. Neurosci. 1992, 12:430-439.
150. Swanson R.A., Yu A.C., Sharp F.R., Chan P.H. Regulation of glycogen content in primary astrocyte culture: Effects of glucose analogues, phenobarbital, and methionine sulfoximine. J. Neurochem. 1989, 52:1359-1365.
151. Taylor C.P. Na+ currents that fail to inactivate. Trends Neurosci. 1993, 16:455-460.
152. Taylor C.P., Weber M.L., Gaughan C.L., Lehning E.J., LoPachin R.M. Oxygen/glucose deprivation in hippocampal slices: Altered intraneuronal elemental composition predicts structural and functional damage. J. Neurosci. 1999, 19:619-629.
153. Tekkok S.B., Goldberg M.P. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J. Neurosci. 2001, 21:4237-4248.
154. Tekkok S.B., Hyrc K.L., Underhill S.M., Goldberg M.P. Na+/Ca2+ exchange blocker KB-R7943 protects axons and oligodendrocytes during oxygen glucose deprivation. Soc. Neurosci. Abstr. 2000, 26:2065.
155. Teng Y.D., Wrathall J.R. Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long -term functional deficits resulting from experimental spinal cord injury. J. Neurosci. 1997, 17:4359-4366.
156. Thorell W.E., Leibrock L.G., Agrawal S.K. Role of RyRs and IP3 receptors after traumatic injury to spinal cord white matter. J. Neurotrauma 2002, 19:335-342.
157. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285.
158. Tsacopoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 1996, 16:877-885.
159. Underhill S.M., Goldberg M.P. Axons potentiate oligodendrocyte vulnerability to excitotoxicity. Soc. Neurosci. Abstr. 299.7 2002.
160. Wang G.K., Brodwick M.S., Eaton D.C., Strichartz G.R. Inhibition of sodium currents by local anesthetics in chloramine-T-treated squid axons. The role of channel activation. J. Gen. Physiol. 1987, 89:645-667.
161. Waxman S.G. Multiple sclerosis as a neuronal disease. Arch Neurol 2000, 57:22-24.
162. Waxman S.G. Transcriptional channelopathies: an emerging class of disorders. Nat. Rev. Neurosci. 2001, 2:652-659.
163. Waxman S.G., Black J.A., Ransom B.R., Stys P.K. Protection of the axonal cytoskeleton in anoxic optic nerve by decreased extracellular calcium. Brain Res. 1993, 614:137-145.
164. The Axon: Structure, Function and Pathophysiology 1995, Oxford University Press, New York. S.G. Waxman, J.D. Kocsis, P.K. Stys (Eds.).
165. Weinshenker B.G. Epidemiology of multiple sclerosis. Neurol Clin 1996, 14:291-308.
166. Wender R., Brown A.M., Fern R., Swanson R.A., Farrell K., Ransom B.R. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 2000, 20:6804-6810.
167. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., Rafols J.A., Krause G.S. Brain ischemia and reperfusion: Molecular mechanisms of neuronal injury. J Neurol Sci 2000, 179:1-33.
168. Wolf J.A., Stys P.K., Lusardi T., Meaney D., Smith D.H. Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J. Neurosci. 2001, 21:1923-1930.
169. Wrathall J.R., Choiniere D., Teng Y.D. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J. Neurosci. 1994, 14:6598-6607.
170. Wrathall J.R., Teng Y.D., Marriott R. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp. Neurol. 1997, 145:565-573.
171. Yam P.S., Dunn L.T., Graham D.I., Dewar D., McCulloch J. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. J Cereb Blood Flow Metab 2000, 20:772-779.
172. Yeh J.Z., Tanguy J. Na channel activation gate modulates slow recovery from use-dependent block by local anesthetics in squid giant axons. Biophys. J. 1985, 47:685-694.
173. Yoshioka A., Bacskai B., Pleasure D. Pathophysiology of oligodendroglial excitotoxicity. J. Neurosci. Res. 1996, 46:427-437.
174. Yoshioka A., Hardy M., Younkin D.P., Grinspan J.B., Stern J.L., Pleasure D. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J. Neurochem. 1995, 64:2442-2448.
175. Yu A.C.H., Gregory G.A., Chan P.H. Hypoxia-induced dysfunctions and injury of astrocytes in primary cell cultures. J. Cereb. Blood Flow Metab. 1989, 9:20-28.
176. Zerangue N., Kavanaugh M.P. Flux coupling in a neuronal glutamate transporter. Nature 1996, 383:634-637.
177. Zhang K., Sejnowski T.J. A universal scaling law between gray matter and white matter of cerebral cortex. Proc Natl Acad Sci U S A 2000, 97:5621-5626.